Literature DB >> 23184399

The impact of deep brain stimulation on the nonmotor symptoms of Parkinson's disease.

Keyoumars Ashkan1, Michael Samuel, Prashanth Reddy, K Ray Chaudhuri.   

Abstract

Deep brain stimulation (DBS) is a well-established therapy for patients with advanced Parkinson's disease (PD) with clear benefits on many of the motor symptoms. The effects of DBS on the nonmotor symptoms are less well examined. Emergence of tools to measure the nonmotor burden in PD is now allowing a more objective assessment of impact of DBS on such symptoms. Here we review the pertinent evidence and conclude that, as a therapy, DBS has a major potential to contribute towards the holistic care of PD patients.

Entities:  

Mesh：

Year:  2012        PMID： 23184399     DOI： 10.1007/s00702-012-0912-x

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN： 0300-9564            Impact factor:   3.575


  24 in total

1.  The benefit of subthalamic deep brain stimulation for pain in Parkinson disease: a 2-year follow-up study.

Authors:  Han-Joon Kim; Beom S Jeon; Jee-Young Lee; Sun Ha Paek; Dong Gyu Kim
Journal:  Neurosurgery       Date:  2012-01       Impact factor: 4.654

Review 2.  Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation.

Authors:  Alfonso Fasano; Antonio Daniele; Alberto Albanese
Journal:  Lancet Neurol       Date:  2012-05       Impact factor: 44.182

3.  The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study.

Authors:  Kallol Ray Chaudhuri; Pablo Martinez-Martin; Richard G Brown; Kapil Sethi; Fabrizio Stocchi; Per Odin; William Ondo; Kazuo Abe; Graeme Macphee; Doug Macmahon; Paolo Barone; Martin Rabey; Alison Forbes; Kieran Breen; Susanne Tluk; Yogini Naidu; Warren Olanow; Adrian J Williams; Sue Thomas; David Rye; Yoshio Tsuboi; Annette Hand; Anthony H V Schapira
Journal:  Mov Disord       Date:  2007-10-15       Impact factor: 10.338

4.  The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease.

Authors:  Pablo Martinez-Martin; Carmen Rodriguez-Blazquez; Monica M Kurtis; K Ray Chaudhuri
Journal:  Mov Disord       Date:  2011-01-24       Impact factor: 10.338

5.  Chronic stimulation of subthalamic nucleus improves levodopa-induced dyskinesias in Parkinson's disease.

Authors:  P Krack; P Limousin; A L Benabid; P Pollak
Journal:  Lancet       Date:  1997-12-06       Impact factor: 79.321

Review 6.  Relationships between deep brain stimulation and impulse control disorders in Parkinson's disease, with a literature review.

Authors:  P Shotbolt; J Moriarty; A Costello; A Jha; A David; K Ashkan; M Samuel
Journal:  Parkinsonism Relat Disord       Date:  2011-09-14       Impact factor: 4.891

7.  Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease.

Authors:  A L Benabid; P Pollak; A Louveau; S Henry; J de Rougemont
Journal:  Appl Neurophysiol       Date:  1987

8.  Lower urinary tract symptoms and bladder control in advanced Parkinson's disease: effects of deep brain stimulation in the subthalamic nucleus.

Authors:  Kristian Winge; Kurt Krøyer Nielsen; Hans Stimpel; Annemette Lokkegaard; Steen Rusborg Jensen; Lene Werdelin
Journal:  Mov Disord       Date:  2007-01-15       Impact factor: 10.338

9.  Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial.

Authors:  Adrian Williams; Steven Gill; Thelekat Varma; Crispin Jenkinson; Niall Quinn; Rosalind Mitchell; Richard Scott; Natalie Ives; Caroline Rick; Jane Daniels; Smitaa Patel; Keith Wheatley
Journal:  Lancet Neurol       Date:  2010-04-29       Impact factor: 44.182

Review 10.  Deep brain stimulation of the subthalamic nucleus in Parkinson's disease 1993-2003: where are we 10 years on?

Authors:  K Ashkan; B Wallace; B A Bell; A L Benabid
Journal:  Br J Neurosurg       Date:  2004-02       Impact factor: 1.596
View more
  7 in total

Review 1.  Current Practice and the Future of Deep Brain Stimulation Therapy in Parkinson's Disease.

Authors:  Leonardo Almeida; Wissam Deeb; Chauncey Spears; Enrico Opri; Rene Molina; Daniel Martinez-Ramirez; Aysegul Gunduz; Christopher W Hess; Michael S Okun
Journal:  Semin Neurol       Date:  2017-05-16       Impact factor: 3.420

Review 2.  A review of lower urinary tract symptoms in patients with Parkinson's disease.

Authors:  Anand V Badri; Rajveer S Purohit; Jason Skenazy; Jeffrey P Weiss; Jerry G Blaivas
Journal:  Curr Urol Rep       Date:  2014-09       Impact factor: 3.092

Review 3.  Mixed effects of deep brain stimulation on depressive symptomatology in Parkinson's disease: a review of randomized clinical trials.

Authors:  N Simay Gökbayrak; Irene Piryatinsky; Rebecca A Gavett; Omar J Ahmed
Journal:  Front Neurol       Date:  2014-08-11       Impact factor: 4.003

Review 4.  Gastrointestinal Dysfunctions in Parkinson's Disease: Symptoms and Treatments.

Authors:  Andrée-Anne Poirier; Benoit Aubé; Mélissa Côté; Nicolas Morin; Thérèse Di Paolo; Denis Soulet
Journal:  Parkinsons Dis       Date:  2016-12-06

Review 5.  The subcortical belly of sleep: New possibilities in neuromodulation of basal ganglia?

Authors:  Harutomo Hasegawa; Richard Selway; Valentina Gnoni; Sandor Beniczky; Steve C R Williams; Meir Kryger; Luigi Ferini-Strambi; Peter Goadsby; Guy D Leschziner; Keyoumars Ashkan; Ivana Rosenzweig
Journal:  Sleep Med Rev       Date:  2020-04-22       Impact factor: 11.609

6.  Nomogram for Predicting Depression Improvement after Deep Brain Stimulation for Parkinson's Disease.

Authors:  Bowen Chang; Chen Ni; Jiaming Mei; Chi Xiong; Peng Chen; Manli Jiang; Chaoshi Niu
Journal:  Brain Sci       Date:  2022-06-28

7.  A Pilot Study Assessing the Effects of Pallidal Deep Brain Stimulation on Sleep Quality and Polysomnography in Parkinson's Patients.

Authors:  Christopher M Tolleson; Kanika Bagai; Arthur S Walters; Thomas L Davis
Journal:  Neuromodulation       Date:  2016-05-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.